Risperdal Mass Tort Case Leads
Reach males who developed gynecomastia (abnormal breast growth) and other hormonal disorders after taking the antipsychotic medication Risperdal (risperidone).
Risperdal Litigation
Risperdal (risperidone), manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is an antipsychotic medication prescribed for schizophrenia, bipolar disorder, and irritability associated with autism. The drug has been linked to gynecomastia, a condition causing abnormal breast tissue growth in males, particularly in boys and young men. Juries have awarded billions in damages, finding that Janssen failed to adequately warn about the risk of gynecomastia and illegally marketed the drug for off-label use in children.
Associated Conditions
- Gynecomastia (abnormal breast growth in males)
- Breast tissue enlargement requiring surgical intervention
- Hormonal disorders and elevated prolactin levels
- Galactorrhea (abnormal breast milk production)
- Psychological distress and emotional harm
- Sexual dysfunction
- Weight gain and metabolic disorders
Claimant Eligibility
- Prescribed Risperdal (risperidone) and developed gynecomastia
- Male patients, particularly boys or young men prescribed the medication
- Experienced abnormal breast tissue growth during or after Risperdal use
- Required surgery (mastectomy) to correct gynecomastia
- Medical records confirming Risperdal prescription and diagnosis
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Risperdal legal marketing campaigns: how we acquire cases
Risperdal case acquisition runs as a multi-channel program, not a single ad buy. Product liability and class action claimants research their condition long before they contact a lawyer, so we meet potential clients at each stage — paid demand capture for people already searching, paid social and traditional media for people who have not yet connected their injury to the litigation, and organic search for the long research tail.
Digital marketing channels
- Google Ads and paid search demand capture
- Meta and paid social prospecting by exposure profile
- Mass tort search engine optimization for the research tail
- OTT and connected TV retargeting
Traditional media channels
- Broadcast and cable TV in qualifying DMAs
- Radio and streaming audio
- Direct response print in occupational verticals
- Earned media and litigation PR support
How the channel mix is built, budgeted, and measured is covered in our mass tort marketing guide. For intake handling once the lead lands, see mass tort intake.
Running a Risperdal mass tort marketing campaign
Common questions from law firms about Risperdal lawsuit lead generation and campaign management.
- What does a Risperdal mass tort marketing campaign include?
- A Risperdal mass tort marketing campaign from Mass Tort Marketing Agency covers multi-channel strategy across Meta, Google PPC, OTT and connected TV, traditional media, and mass tort search engine optimization; compliant ad creative; TCPA-verified intake; claimant qualification against your Risperdal case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- How do you generate Risperdal mass tort case leads?
- Risperdal mass tort case leads are generated through paid social and search campaigns aimed at the specific exposure and injury profile of the litigation, supported by organic content that captures claimants already researching their condition. Every lead is a real, consented claimant — we do not buy aggregated lists or resell shared data.
- What do Risperdal legal marketing campaigns cost?
- Risperdal legal marketing campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. Cost per retainer varies by tort based on claimant prevalence, media competition, and how tight your case criteria are. We scope a per-tort figure before any spend commitment.
- Are Risperdal leads exclusive to my firm?
- Yes. Every Risperdal lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Risperdal claimants qualified before delivery?
- Each Risperdal claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a certified TrustedForm or Jornaya consent record — preserving the exact disclosure language shown at submission — before the lead reaches your intake team.
- How fast can a Risperdal case acquisition program scale?
- A Risperdal mass tort case acquisition program typically moves from scoping to live media inside two weeks, with volume ramped against your docket capacity rather than pushed to a fixed budget. Volume can be scaled up or down by tort month to month as the litigation posture changes.
Get Risperdal campaign pricing on a 30-minute call
We will walk your Risperdal case criteria, current cost per signed retainer, and the volume your docket can absorb — and tell you plainly if this tort is not a fit right now.
See how every lead is qualified on our mass tort leads page, read the full mass tort marketing guide, or compare providers in our top mass tort marketing firms guide.